Barriers to optimizing inflammatory bowel disease care in the United States

被引：0

作者：

Spencer, Elizabeth A. ^{[2
]}

Abbasi, Sadeea ^{[3
]}

Kayal, Maia ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, One Gustave L Levy Pl Box 1069, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol, New York, NY USA

[3] Div Gastroenterol, Cedars Sinai Santa Monica Gastroenterol, Santa Monica, CA USA

来源：

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2023年 / 16卷

关键词：

barriers; inflammatory bowel disease; insurance;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions.

引用

页数：14

共 50 条

[1] Barriers to optimizing inflammatory bowel disease care in the United States
Spencer, Elizabeth A.
Abbasi, Sadeea
Kayal, Maia
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
[2] Optimizing the Transition and Transfer of Care in Pediatric Inflammatory Bowel Disease
Fishman, Laurie N.
Ding, Julia
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2023, 52 (03) : 629 - 644
[3] Healthcare Access for Patients With Inflammatory Bowel Disease in the United States: A Survey by the Crohn's & Colitis Foundation
Jordan, Ariel A.
Bhat, Shubha
Ali, Tauseef
Brunskill, Sarah R.
Clusen, Nancy A.
Maltz, Ross M.
Moise, Ced
Sun, Xiaofan
Thomas, Harry J.
Ray, Cassie
Harkins-Schwarz, Mary
Ehrlich, Orna G.
INFLAMMATORY BOWEL DISEASES, 2024,
[4] Hospitalizations for Inflammatory Bowel Disease: Profile of the Uninsured in the United States
Nguyen, Geoffrey C.
Sam, Justina
Murthy, Sanjay K.
Kaplan, Gilaad G.
Tinmouth, Jill M.
LaVeist, Thomas A.
INFLAMMATORY BOWEL DISEASES, 2009, 15 (05) : 726 - 733
[5] Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis
Prokopic, Michal
Gilca-Blanariux, Georgiana
Lietava, Peter
Trifan, Anca
Pietrzak, Anna
Ladic, Agata
Brinar, Marko
Turcan, Svetlana
Molnar, Tamas
Banovcin, Peter
Lukas, Milan
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
[6] Optimizing the use of thiopurines in inflammatory bowel disease
Goel, Rishi M.
Blaker, Paul
Mentzer, Alex
Fong, Steven C. M.
Marinaki, Anthony M.
Sanderson, Jeremy D.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (03) : 138 - 146
[7] Optimizing Thiopurine Therapy in Inflammatory Bowel Disease
Chevaux, Jean-Baptiste
Peyrin-Biroulet, Laurent
Sparrow, Miles P.
INFLAMMATORY BOWEL DISEASES, 2011, 17 (06) : 1428 - 1435
[8] Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
Hakizimana, Ali
Ahmed, Iftikhar
Russell, Rachel
Wright, Mark
Afzal, Nadeem A.
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (25) : 4473 - 4479
[9] Optimizing immunomodulator therapy for inflammatory bowel disease
Marla C. Dubinsky
Current Gastroenterology Reports, 2003, 5 (6) : 506 - 511
[10] Dietary Intake of Pregnant Women with and without Inflammatory Bowel Disease in the United States
Olendzki, Barbara C.
Hsiao, Bi-Sek
Weinstein, Kaitlyn
Chen, Rosemary
Frisard, Christine
Madziar, Camilla
Picker, Mellissa
Pauplis, Connor
Maldonado-Contreras, Ana
Peter, Inga
NUTRIENTS, 2023, 15 (11)

← 1 2 3 4 5 →